“Structural Biology in Industry – Proteros overview”
_
Date and Time
5:00 PM – 6:30 PM Wednesday, January 22th, 2025
Location
Online (Zoom)
Speakers:
Eva Cunha, PhD
Profile:
2006 Master (Bioinformatics), University of Lisbon, Portugal
2013 Ph.D. (Biophysics), Jonhs Hopkins University, USA
2013-2015 Postdoctoral Researcher with Dr. N. Abrescia, CIC-Biogune, Spain
2016-2018 Postdoctoral Researcher with Dr. W. Kuhlbrandt, Max-Planck-Institute for Biophysics, Germany
2018-2021 Researcher, University of Oslo, Norway
2021-2022 Principal Investigator, University of Oslo, Norway
2022-2023 Director for cryoEM, Proteros Biostructures, Germany
2024-Present Department Head and BU co-head for cryoEM, Proteros Biostructures, Germany
Stephan Krapp, PhD
Profile:
1997 Master of Biochemistry, Imperial College, UK / University of Bayreuth, Germany
2002 Ph.D. in Protein Crystallography, Max-Planck-Institute of Biochemistry, Martinsried, Germany (Prof. Dr. Robert Huber)
2003 Research scientist and project manager at Proteros Biostructures, Martinsried, Germany
2010 Department Head of Structural Biology at Proteros Biostructures, Martinsried, Germany
2022 – present: Business Unit Head x-ray crystallography and co-Department head x-ray crystallography at Proteros Biostructures, Martinsried, Germany
Abstract
Proteros offers cutting-edge cryo-electron microscopy (cryoEM) and x-ray crystallography services tailored to accelerate drug discovery by providing high-resolution structural insights into challenging pharmaceutical targets. Our platform integrates state-of-the-art cryoEM and x-ray instrumentation, proprietary workflows, and deep expertise in structure determination to deliver actionable data for small-molecule and biologics programs.
Proteros specializes in resolving protein structures, protein-ligand complexes, and multi-protein assemblies with precision, even for challenging targets like membrane proteins. By enabling atomic resolution insights, our services empower researchers to drive structure-based drug design, optimize lead compounds, and elucidate mechanisms of action. This talk will highlight Proteros’ streamlined processes, success stories, and how our structural biology capabilities bridge the gap between molecular structures and therapeutic breakthroughs. Case studies will include GPCR´s (e.g. GLP1R), ion channels (e.g. Kv.1.3) Kinases (e.g. TAK1, cRAF-14-3-3) and others.